Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/200021
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis |
Autor: | Morales, Paula CSIC ORCID; Gómez-Cañas, María; Navarro, Gemma; Hurst, D. P.; Carrillo-Salinas, F. J. CSIC ORCID; Lagartera, Laura CSIC ORCID; Pazos, Ruth; Goya, Pilar CSIC ORCID; Reggio, Patricia; Guaza, Carmen CSIC ORCID ; Franco, Rafael; Fernández-Ruiz, Javier; Jagerovic, Nadine CSIC ORCID | Fecha de publicación: | 2016 | Editor: | American Chemical Society | Citación: | Journal of Medicinal Chemistry 59(14): 6753-6771 (2016) | Resumen: | A combination of molecular modeling and structure–activity relationship studies has been used to fine-tune CB2 selectivity in the chromenopyrazole ring, a versatile CB1/CB2 cannabinoid scaffold. Thus, a series of 36 new derivatives covering a wide range of structural diversity has been synthesized, and docking studies have been performed for some of them. Biological evaluation of the new compounds includes, among others, cannabinoid binding assays, functional studies, and surface plasmon resonance measurements. The most promising compound [43 (PM226)], a selective and potent CB2 agonist isoxazole derivative, was tested in the acute phase of Theiler’s murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD), a well-established animal model of primary progressive multiple sclerosis. Compound 43 dampened neuroinflammation by reducing microglial activation in the TMEV. | Versión del editor: | http://dx.doi.org/10.1021/acs.jmedchem.6b00397 | URI: | http://hdl.handle.net/10261/200021 | DOI: | 10.1021/acs.jmedchem.6b00397 | ISSN: | 0022-2623 | E-ISSN: | 1520-4804 |
Aparece en las colecciones: | (IC) Artículos (IQM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
12
checked on 21-abr-2024
SCOPUSTM
Citations
32
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
30
checked on 29-feb-2024
Page view(s)
167
checked on 21-abr-2024
Download(s)
31
checked on 21-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.